HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry-Reference-Cited by-同舟云学术

HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry

Published:2017-07-11 Issue:4 Volume:90 Page:228-233
ISSN:2059-2302
Container-title:HLA
language:en
Short-container-title:HLA

Author:

Henriksen E. K. K.¹²³⁴^ORCID,Viken M. K.³⁵^ORCID,Wittig M.⁶,Holm K.¹²³⁴,Folseraas T.¹²³⁴⁷,Mucha S.⁶,Melum E.¹²³⁷,Hov J. R.¹²³⁴⁷,Lazaridis K. N.⁸,Juran B. D.⁸,Chazouillères O.⁹,Färkkilä M.¹⁰,Gotthardt D. N.¹¹,Invernizzi P.¹²,Carbone M.¹²,Hirschfield G. M.¹³,Rushbrook S. M.¹⁴,Goode E.¹⁵,Ponsioen C. Y.¹⁶,Weersma R. K.¹⁷,Eksteen B.¹⁸,Yimam K. K.¹⁹,Gordon S. C.²⁰,Goldberg D.²¹,Yu L.²²,Bowlus C. L.²³,Franke A.⁶,Lie B. A.³⁵²⁴,Karlsen T. H.¹²³⁴⁷,

Affiliation:

1. Norwegian PSC Research Center, Department of Transplantation Medicine, Division of Surgery, Inflammatory Medicine and Transplantation; Oslo University Hospital Rikshospitalet; Oslo Norway

2. Research Institute of Internal Medicine, Division of Surgery, Inflammatory Medicine and Transplantation; Oslo University Hospital Rikshospitalet; Oslo Norway

3. K.G. Jebsen Inflammation Research Centre, Institute of Clinical Medicine; University of Oslo; Oslo Norway

4. Institute of Clinical Medicine, Faculty of Medicine; University of Oslo; Oslo Norway

5. Department of Immunology; Oslo University Hospital Rikshospitalet; Oslo Norway

6. Institute of Clinical Molecular Biology; Kiel University; Kiel Germany

7. Section of Gastroenterology, Department of Transplantation Medicine, Division of Surgery, Inflammatory Medicine and Transplantation; Oslo University Hospital Rikshospitalet; Oslo Norway

8. Center for Basic Research in Digestive Diseases, Division of Gastroenterology and Hepatology; Mayo Clinic College of Medicine; Rochester Minnesota

9. Hôpital Saint-Antoine, Service d'Hépatologie, INSERM, UMR_S 938; CDR Saint-Antoine, and Sorbonne Universités, UPMC Univ Paris 06; Paris France

10. Helsinki University and Clinic of Gastroenterology; Helsinki University Hospital; Helsinki Finland

11. Department of Gastroenterology, Infectious Diseases and Intoxications; University Hospital of Heidelberg; Heidelberg Germany

12. Program for Autoimmune Liver Diseases, International Center for Digestive Health, Department of Medicine and Surgery; University of Milan-Bicocca; Milan Italy

13. Centre for Liver Research and NIHR Birmingham Liver Biomedical Research Unit, Institute of Biomedical Research, Institute of Immunology and Immunotherapy; University of Birmingham; Birmingham UK

14. The Department of Gastroenterology; Norfolk and Norwich University Hospitals NHS Foundation Trust; Norfolk UK

15. Wellcome Trust Sanger Institute, Hinxton and Institute of Metabolic Science; University of Cambridge; Cambridge UK

16. Department of Gastroenterology and Hepatology; Academic Medical Center; Amsterdam the Netherlands

17. Department of Gastroenterology and Hepatology; University of Groningen, University Medical Center Groningen; Groningen the Netherlands

18. Snyder Institute for Chronic Diseases, Division of Gastroenterology; University of Calgary; Calgary Canada

19. Division of Hepatology and Liver Transplantation; California Pacific Medical Center; San Francisco California

20. Division of Gastroenterology and Hepatology, Henry Ford Health System; Detroit Michigan

21. Division of Gastroenterology, Department of Medicine; University of Pennsylvania; Philadelphia Pennsylvania

22. Department of Medicine; University of Washington; Seattle Washington

23. Division of Gastroenterology and Hepatology; University of California Davis School of Medicine; Sacramento California

24. Department of Medical Genetics; University of Oslo and Oslo University Hospital Ullevål; Oslo Norway

Publisher

Wiley

Subject

Genetics,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tan.13076/fullpdf

Reference33 articles.

1. Update on primary sclerosing cholangitis;Karlsen;Dig Liver Dis,2010

2. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis;Bergquist;Clin Gastroenterol Hepatol,2008

3. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease;Schrumpf;Scand J Gastroenterol,1982

4. Association of primary sclerosing cholangitis with HLA-B8;Chapman;Gut,1983

5. Novel insights into autoimmune liver diseases provided by genome-wide association studies;Mells;J Autoimmun,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial glycoprotein 2 (GP2) in gallstones, bile fluid and peribiliary glands of patients with primary sclerosing cholangitis;Clinica Chimica Acta;2024-08

2. Distinct metabolomic and lipidomic profiles in serum samples of patients with primary sclerosing cholangitis;Frontiers in Medicine;2024-06-04

3. Diagnostic Tests in Primary Sclerosing Cholangitis;Clinics in Liver Disease;2024-02

4. Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies;Cancers;2023-10-11

5. Beyond genome-wide association studies: Investigating the role of noncoding regulatory elements in primary sclerosing cholangitis;Hepatology Communications;2023-09-27